Advertisement

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

ACCEPT AND CLOSE

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member?  

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

  • Access to 6 digital C&EN articles per month on cen.acs.org
  • Weekly delivery of the C&EN Essential newsletter
JOIN NOW
Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW
Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

  • Unlimited access to C&EN’s daily news coverage on cen.acs.org
  • Weekly delivery of the C&EN Magazine in print or digital format
  • Access to our Chemistry News by C&EN mobile app
  • Significant discounts on registration for most ACS-sponsored meetings
ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

Thank you!

Your account has been created successfully, and a confirmation email is on the way.

Your username is now your ACS ID.

ENJOY UNLIMITED ACCES TO C&EN
09919-cover1-illus.jpg
« Prev
Next »
09919-cover1-illus.jpg
Copyright © 2024 American Chemical Society

May 24, 2021 Cover

Volume 99, Issue 19

Experts say oral antivirals, long out of reach, could play a critical role in extinguishing the current coronavirus pandemic and preventing others from emerging

Cover image:Experts say oral antivirals, long out of reach, could play a critical role in extinguishing the current coronavirus pandemic and preventing others from emerging

Credit: Luisa Jung

Full Article
Volume 99 | Issue 19
« Prev
Next »

All Issues

Quote of the Week

“We want to be ready and equipped for future pandemics.”

Charlotte Allerton, head of medicine design, Pfizer

Drug Discovery

To conquer COVID-19, create the perfect pill

Why are antivirals so hard to develop?

With few good targets and limited financial incentives, the field of antiviral drug discovery has lagged. The COVID-19 pandemic might be awakening the world to the problem

Betting big on the smallest molecule

Megaprojects for green hydrogen are one part of Europe’s move to a low-carbon economy

  • Materials

    Periodic Graphics: The materials science of cycling

    Chemical educator and Compound Interest blogger Andy Brunning explores the alloys and polymers used in bicycle equipment.

  • Undergraduate Education

    Clearing the way for reform of general chemistry classes

    Yearslong ACS project seeks to refresh the curriculum by drawing on the way high schoolers learn science

  • Pesticides

    How environmental scientist Melanie Kah changed her mind about nanopesticides

    The University of Auckland researcher evaluates the risks and benefits of nanoproducts for crop protection

ADVERTISEMENT

Science Concentrates

image name
Gene Therapy

One-time CRISPR hit lowers cholesterol in monkeys

Verve Therapeutics demonstrates long-term LDL reduction for base editor therapy

Business & Policy Concentrates

More
ADVERTISEMENT

EDITORIAL

REACTIONS FROM OUR READERS

ACS NEWS

NEWSCRIPTS

image

Shape-changing pasta and edible-insect nutrition

 

Job listings

visit
ADVERTISEMENT